DISCOUNT ZERTIFIKAT - BRISTOL-MYERS SQUIBB | Market Closed - Bid/Ask 02:04:53 2024-06-18 pm EDT | Pre-market 02:21:21 am | |||
| 33.8 EUR | -0.18% |
|
34.18 | +1.14% |
| Current month | +0.99% | ||
| 1 month | -1.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-18 | 33.8 | -0.18% |
| 24-06-17 | 33.86 | -0.94% |
| 24-06-14 | 34.18 | +0.12% |
| 24-06-13 | 34.14 | -0.03% |
| 24-06-12 | 34.15 | -0.84% |
Real-time Boerse Frankfurt Warrants
Last update June 18, 2024 at 02:04 pm EDT
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Vontobel
|
| WKN | VM8MBZ |
| ISIN | DE000VM8MBZ1 |
| Date issued | 2024-01-17 |
| Maturity | 2024-12-20 (185 Days) |
| Parity | 1 : 1 |
| Emission price | 34.79 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 35.48 € |
|---|---|
| Lowest since issue | 33.18 € |
| Spread | 0.69 € |
| Spread % | 2.00% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.81
USD
Average target price
53.19
USD
Spread / Average Target
+30.35%
- Stock Market
- Certificates
- Certificat
